Apr. 9, 2025 — A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, according to new ... Apr. 7, 2025 — A study ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

These mysterious droplets, known ... AI Tool to Better Assess Parkinson's Disease, Other Movement Disorders Apr. 14, 2025 — A groundbreaking open-source computer program uses artificial ...

此外，两项研究的巧妙设计体现了转化医学的智慧。 美国团队选择壳核作为移植靶点，而非多巴胺神经元原生的黑质区。这是因为帕金森病中黑质到壳核的神经通路断裂，直接将新细胞植入“信号接收端”更能规避复杂的神经环路重建。

Combining pioneering iPSC technology and patented live cell bioimaging, LumiSTAR is opening up exciting new possibilities in the treatment of various diseases and the development of innovative new dru ...

Evidence suggests that in Parkinson’s disease, a breakdown in lysosomal function allows lipids to build up within cells. Variants of the GBA1 gene, the strongest genetic risk factor for sporadic PD, ...

National Center for Advancing Translational Sciences A treatment that could replenish cells in the brains of Parkinson’s disease patients caused no major negative reactions in two small ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness ...

Illing, who made this known in a press statement issued on Saturday, noted that up to 15 per cent of Parkinson’s cases can currently be linked to deletions or mutations in people’s genes.

HONOLULU (KHON2) — April is Parkinson’s Awareness Month, a time to highlight the effects this disease can have on people and those around them. Parkinson’s is a common brain disorder that ...